Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma
2025 · Cell Communication and Signaling · 4 citations
https://doi.org/10.1186/s12964-025-02242-8
K
Kyoung-Seok Oh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
78
Citations
4
h-index
4
i10-index
Kyoung-Seok Oh is an academic researcher from Seoul National University. The author has contributed to research in topics: PARP inhibition in cancer therapy & Cholangiocarcinoma and Gallbladder Cancer Studies & RNA modifications and cancer. The author has an h-index of 4, co-authored 23 publications.
Papers by this author
worksFadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression
2025 · Cell Communication and Signaling · 1 citations
https://doi.org/10.1186/s12964-025-02521-4
YAP as a therapeutic target to reverse trastuzumab resistance
2025 · Gastric Cancer · 0 citations
https://doi.org/10.1007/s10120-025-01630-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat